You are here

  • Home
  • Archive
  • Volume 20, Issue 6
  • Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention

Article metrics

Article menu
Download PDFPDF
Economic analysis
Cost-effectiveness
Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention

 

Online download statistics by month:

Online download statistics by month: September 2015 to March 2024

AbstractFullPdf
Sep 2015117918
Oct 20153042
Nov 2015962514
Dec 2015112128
Jan 201680514
Feb 20163443
Mar 20162627
Apr 201648729
May 20165141
Jun 20162014
Jul 20161233
Aug 20161762
Sep 20162221
Oct 20161043
Nov 20161944
Dec 20165611
Jan 20172400
Feb 20171400
Mar 20171253
Apr 20171744
May 20172300
Jun 20171311
Jul 20171800
Aug 20173643
Sep 20174711
Oct 20175931
Nov 20173631
Dec 20174040
Jan 20184230
Feb 20183811
Mar 20184610
Apr 20182631
May 20183320
Jun 20185932
Jul 20184820
Aug 20186211
Sep 20183320
Oct 20185821
Nov 20184421
Dec 20183900
Jan 20193903
Feb 20196222
Mar 20192910
Apr 20193021
May 20192010
Jun 20191520
Jul 20191551
Aug 20191801
Sep 20193140
Oct 20193000
Nov 20191731
Dec 20192800
Jan 20202910
Feb 20201910
Mar 20203000
Apr 2020800
May 20201500
Jun 20201600
Jul 20204511
Aug 2020800
Sep 20202802
Oct 20203200
Nov 20203702
Dec 20201200
Jan 20212000
Feb 20211700
Mar 20213010
Apr 2021700
Jul 2021210
Aug 2021662
Sep 2021110
Oct 20211400
Nov 20213810
Dec 20212710
Jan 20221402
Feb 20222600
Mar 20223202
Apr 20222200
May 20224000
Jun 20223203
Jul 20221821
Aug 20224520
Sep 20224240
Oct 20224013
Nov 20222802
Dec 20221300
Jan 20231000
Feb 20235400
Mar 2023400
Apr 2023500
May 20231500
Jun 20231300
Jul 20232000
Aug 20231400
Sep 2023800
Oct 20232310
Nov 20233200
Dec 20232710
Jan 20241200
Feb 20242200
Mar 20243760
Total3040191164